Cargando…

Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service

BACKGROUND: Prenatal exome sequencing (ES) for the diagnosis of fetal anomalies was implemented nationally in England in October 2020 by the NHS Genomic Medicine Service (GMS). is the GMS is based around seven regional Genomic Laboratory Hubs (GLHs). Prenatal ES has the potential to significantly im...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Melissa, Ellard, Sian, Fisher, Jane, Fulop, Naomi, Knight, Marian, Kroese, Mark, Ledger, Jean, Leeson-Beevers, Kerry, McEwan, Alec, McMullan, Dominic, Mellis, Rhiannon, Morris, Stephen, Parker, Michael, Tapon, Dagmar, Baple, Emma, Blackburn, Laura, Choudry, Asya, Lafarge, Caroline, McInnes-Dean, Hannah, Peter, Michelle, Ramakrishnan, Rema, Roberts, Lauren, Searle, Beverly, Smith, Emma, Walton, Holly, Wynn, Sarah L., Han Wu, Wing, Chitty, Lyn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613246/
https://www.ncbi.nlm.nih.gov/pubmed/35935673
http://dx.doi.org/10.3310/nihropenres.13247.2
_version_ 1783605457714151424
author Hill, Melissa
Ellard, Sian
Fisher, Jane
Fulop, Naomi
Knight, Marian
Kroese, Mark
Ledger, Jean
Leeson-Beevers, Kerry
McEwan, Alec
McMullan, Dominic
Mellis, Rhiannon
Morris, Stephen
Parker, Michael
Tapon, Dagmar
Baple, Emma
Blackburn, Laura
Choudry, Asya
Lafarge, Caroline
McInnes-Dean, Hannah
Peter, Michelle
Ramakrishnan, Rema
Roberts, Lauren
Searle, Beverly
Smith, Emma
Walton, Holly
Wynn, Sarah L.
Han Wu, Wing
Chitty, Lyn S.
author_facet Hill, Melissa
Ellard, Sian
Fisher, Jane
Fulop, Naomi
Knight, Marian
Kroese, Mark
Ledger, Jean
Leeson-Beevers, Kerry
McEwan, Alec
McMullan, Dominic
Mellis, Rhiannon
Morris, Stephen
Parker, Michael
Tapon, Dagmar
Baple, Emma
Blackburn, Laura
Choudry, Asya
Lafarge, Caroline
McInnes-Dean, Hannah
Peter, Michelle
Ramakrishnan, Rema
Roberts, Lauren
Searle, Beverly
Smith, Emma
Walton, Holly
Wynn, Sarah L.
Han Wu, Wing
Chitty, Lyn S.
author_sort Hill, Melissa
collection PubMed
description BACKGROUND: Prenatal exome sequencing (ES) for the diagnosis of fetal anomalies was implemented nationally in England in October 2020 by the NHS Genomic Medicine Service (GMS). is the GMS is based around seven regional Genomic Laboratory Hubs (GLHs). Prenatal ES has the potential to significantly improve NHS prenatal diagnostic services by increasing genetic diagnoses and informing prenatal decision-making. Prenatal ES has not previously been offered routinely in a national healthcare system and there are gaps in knowledge and guidance. METHODS: Our mixed-methods evaluation commenced in October 2020, aligning with the start date of the NHS prenatal ES service . Study design draws on a framework developed in previous studies of major system innovation. There are five interrelated workstreams. Workstream-1 will use interviews and surveys with professionals, non-participant observations and documentary analysis to produce in-depth case studies across all GLHs. Data collection at multiple time points will track changes over time. In Workstream-2 qualitative interviews with parents offered prenatal ES will explore experiences and establish information and support needs. Workstream-3 will analyse data from all prenatal ES tests for nine-months to establish service outcomes (e.g. diagnostic yield, referral rates, referral sources). Comparisons between GLHs will identify factors (individual or service-related) associated with any variation in outcomes. Workstream-4 will identify and analyse practical ethical problems. Requirements for an effective ethics framework for an optimal and equitable service will be determined. Workstream-5 will assess costs and cost-effectiveness of prenatal ES versus standard tests and evaluate costs of implementing an optimal prenatal ES care pathway. Integration of findings will determine key features of an optimal care pathway from a service delivery, parent and professional perspective. DISCUSSION: The proposed formative and summative evaluation will inform the evolving prenatal ES service to ensure equity of access, high standards of care and benefits for parents across England.
format Online
Article
Text
id pubmed-7613246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-76132462022-08-05 Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service Hill, Melissa Ellard, Sian Fisher, Jane Fulop, Naomi Knight, Marian Kroese, Mark Ledger, Jean Leeson-Beevers, Kerry McEwan, Alec McMullan, Dominic Mellis, Rhiannon Morris, Stephen Parker, Michael Tapon, Dagmar Baple, Emma Blackburn, Laura Choudry, Asya Lafarge, Caroline McInnes-Dean, Hannah Peter, Michelle Ramakrishnan, Rema Roberts, Lauren Searle, Beverly Smith, Emma Walton, Holly Wynn, Sarah L. Han Wu, Wing Chitty, Lyn S. NIHR Open Res Study Protocol BACKGROUND: Prenatal exome sequencing (ES) for the diagnosis of fetal anomalies was implemented nationally in England in October 2020 by the NHS Genomic Medicine Service (GMS). is the GMS is based around seven regional Genomic Laboratory Hubs (GLHs). Prenatal ES has the potential to significantly improve NHS prenatal diagnostic services by increasing genetic diagnoses and informing prenatal decision-making. Prenatal ES has not previously been offered routinely in a national healthcare system and there are gaps in knowledge and guidance. METHODS: Our mixed-methods evaluation commenced in October 2020, aligning with the start date of the NHS prenatal ES service . Study design draws on a framework developed in previous studies of major system innovation. There are five interrelated workstreams. Workstream-1 will use interviews and surveys with professionals, non-participant observations and documentary analysis to produce in-depth case studies across all GLHs. Data collection at multiple time points will track changes over time. In Workstream-2 qualitative interviews with parents offered prenatal ES will explore experiences and establish information and support needs. Workstream-3 will analyse data from all prenatal ES tests for nine-months to establish service outcomes (e.g. diagnostic yield, referral rates, referral sources). Comparisons between GLHs will identify factors (individual or service-related) associated with any variation in outcomes. Workstream-4 will identify and analyse practical ethical problems. Requirements for an effective ethics framework for an optimal and equitable service will be determined. Workstream-5 will assess costs and cost-effectiveness of prenatal ES versus standard tests and evaluate costs of implementing an optimal prenatal ES care pathway. Integration of findings will determine key features of an optimal care pathway from a service delivery, parent and professional perspective. DISCUSSION: The proposed formative and summative evaluation will inform the evolving prenatal ES service to ensure equity of access, high standards of care and benefits for parents across England. F1000 Research Limited 2022-07-18 /pmc/articles/PMC7613246/ /pubmed/35935673 http://dx.doi.org/10.3310/nihropenres.13247.2 Text en Copyright: © 2022 Hill M et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Hill, Melissa
Ellard, Sian
Fisher, Jane
Fulop, Naomi
Knight, Marian
Kroese, Mark
Ledger, Jean
Leeson-Beevers, Kerry
McEwan, Alec
McMullan, Dominic
Mellis, Rhiannon
Morris, Stephen
Parker, Michael
Tapon, Dagmar
Baple, Emma
Blackburn, Laura
Choudry, Asya
Lafarge, Caroline
McInnes-Dean, Hannah
Peter, Michelle
Ramakrishnan, Rema
Roberts, Lauren
Searle, Beverly
Smith, Emma
Walton, Holly
Wynn, Sarah L.
Han Wu, Wing
Chitty, Lyn S.
Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title_full Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title_fullStr Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title_full_unstemmed Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title_short Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
title_sort optimising exome prenatal sequencing services (express): a study protocol to evaluate rapid prenatal exome sequencing in the nhs genomic medicine service
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613246/
https://www.ncbi.nlm.nih.gov/pubmed/35935673
http://dx.doi.org/10.3310/nihropenres.13247.2
work_keys_str_mv AT hillmelissa optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT ellardsian optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT fisherjane optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT fulopnaomi optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT knightmarian optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT kroesemark optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT ledgerjean optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT leesonbeeverskerry optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT mcewanalec optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT mcmullandominic optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT mellisrhiannon optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT morrisstephen optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT parkermichael optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT tapondagmar optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT bapleemma optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT blackburnlaura optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT choudryasya optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT lafargecaroline optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT mcinnesdeanhannah optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT petermichelle optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT ramakrishnanrema optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT robertslauren optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT searlebeverly optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT smithemma optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT waltonholly optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT wynnsarahl optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT hanwuwing optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice
AT chittylyns optimisingexomeprenatalsequencingservicesexpressastudyprotocoltoevaluaterapidprenatalexomesequencinginthenhsgenomicmedicineservice